Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. age 18 years of age or older who can provide informed consent. 2. persons who have been diagnosed with covid-19 and now in post-acute recovery phase. 3. persons who are in care with access to primary care for post covid infection or pacs. 4. ability to read and write in the english language and follow study-related procedures. 5. ability to have mail/ study drug delivered to an address and/or p.o. box in the recipient's name. 6. ability to participate in telemedicine visits/communication. 7. if a woman of childbearing age, willing to use a dual method of contraception (barrier and/or hormonal).

inclusion criteria: 1. age 18 years of age or older who can provide informed consent. 2. persons who have been diagnosed with covid-19 and now in post-acute recovery phase. 3. persons who are in care with access to primary care for post covid infection or pacs. 4. ability to read and write in the english language and follow study-related procedures. 5. ability to have mail/ study drug delivered to an address and/or p.o. box in the recipient's name. 6. ability to participate in telemedicine visits/communication. 7. if a woman of childbearing age, willing to use a dual method of contraception (barrier and/or hormonal).

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: age 18 years of age or older who can provide informed consent. persons who have been diagnosed with covid-19 and now in post-acute recovery phase. persons who are in care with access to primary care for post covid infection or pacs. ability to read and write in the english language and follow study-related procedures. ability to have mail/ study drug delivered to an address and/or p.o. box in the recipient's name. ability to participate in telemedicine visits/communication. if a woman of childbearing age, willing to use a dual method of contraception (barrier and/or hormonal).

inclusion criteria: age 18 years of age or older who can provide informed consent. persons who have been diagnosed with covid-19 and now in post-acute recovery phase. persons who are in care with access to primary care for post covid infection or pacs. ability to read and write in the english language and follow study-related procedures. ability to have mail/ study drug delivered to an address and/or p.o. box in the recipient's name. ability to participate in telemedicine visits/communication. if a woman of childbearing age, willing to use a dual method of contraception (barrier and/or hormonal).

April 6, 2021, 12:31 a.m. usa

inclusion criteria: 1. age 18 years of age or older who can provide informed consent. 2. persons who have been diagnosed with covid-19 and now in post-acute recovery phase. 3. persons who are in care with access to primary care for post covid infection or pacs. 4. ability to read and write in the english language and follow study-related procedures. 5. ability to have mail/ study drug delivered to an address and/or p.o. box in the recipient's name. 6. ability to participate in telemedicine visits/communication. 7. if a woman of childbearing age, willing to use a dual method of contraception (barrier and/or hormonal).

inclusion criteria: 1. age 18 years of age or older who can provide informed consent. 2. persons who have been diagnosed with covid-19 and now in post-acute recovery phase. 3. persons who are in care with access to primary care for post covid infection or pacs. 4. ability to read and write in the english language and follow study-related procedures. 5. ability to have mail/ study drug delivered to an address and/or p.o. box in the recipient's name. 6. ability to participate in telemedicine visits/communication. 7. if a woman of childbearing age, willing to use a dual method of contraception (barrier and/or hormonal).